Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EchoNext

K-Number: K260332 · 2026-06-08

ApplicantPathwai, Inc.
Decision Date2026-06-08
Product CodeQXO
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

EchoNext is the device name listed in this FDA 510(k) record. The listed applicant is Pathwai, Inc.. It received FDA 510(k) clearance on 2026-06-08 under 510(k) number K260332. The device is classified under product code QXO. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EchoNext?

EchoNext is a medical device that received FDA 510(k) clearance on 2026-06-08. The listed applicant is Pathwai, Inc.. The 510(k) number is K260332.

When did EchoNext receive FDA 510(k) clearance?

EchoNext received FDA 510(k) clearance on 2026-06-08, under 510(k) number K260332.

Who is the listed applicant for EchoNext?

The FDA 510(k) record lists Pathwai, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for EchoNext?

The FDA product code for EchoNext is QXO.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.